Navigation Links
NeoClinical Launches Neo PayPerPatient Clinical Trial Recruitment
Date:2/20/2013

Palo Alto, CA/ Sydney, Australia (PRWEB) February 20, 2013

NeoClinical™, the leading digital clinical trial recruitment agency for Australia, New Zealand and Asian markets today officially launched its latest recruitment product, Neo PayPerPatient. Neo PayPerPatient has emerged from 6 months of beta testing, including regulatory compliance, and integration of some of the latest online consumer engagement software and tools.Neo PayPerPatient has already built powerful databases of people wanting more information about the latest clinical trials for conditions including gout, arthritis, Alzheimer’s, menopause, diabetes, prostate cancer and asthma.

Get the PayPerPatient Data Sheet here.

Neo PayPerPatient is a risk share pay-as-you-go solution for new studies or current studies that are under-performing and need a boost to recruitment.Sponsors only pay a nominal fee for partially screened patients then a moderate fee for those that proceed to full enrolment. NeoClinical™ manages all the rest.

NeoClinical™‘s advertising and PR expertise as well as the team’s considerable online and social media experience is already delivering results for clients – saving money and most importantly time. NeoClinical™ study recruitment campaigns feature innovative and EC compliant advertising, public relations and online content marketing campaigns. With more than 80% of internet users seeking health information online and a third of US adults online to look at health information, getting in front of people online is key.

“Dr. Google is where it is all happening, but you need to give people quality informative content that answers their online search,” said co-founder Susan Fitzpatrick-Napier. “NeoClinical™ is a trusted source for original and authentic health news that informs and updates our potential patients.”

NeoClinical™ typically achieves referral conversion rates of 40-60% and recently achieved a 63% conversion rate for a New Zealand Study.

“For too long companies have been spending valuable time and money searching for people. Don’t waste money finding people you don’t need. Just make it easy for people you need to find you,” said Fitzpatrick-Napier.

For more information about the latest research and new clinical trials please visit http://www.NeoClinical.com.

About NeoClinical™ http://www.neoclinical.com
NeoClinical™ is the region's foremost clinical trial marketing agency dedicated to sharing news on the latest clinical research in Australia, New Zealand, and Asia including Korea, Taiwan, Malaysia, India and China.
NeoClinical™ uses the latest population health data and media consumption data to communicate via a sophisticated mix of public relations, advertising and online content marketing. This is combined with the highest level of reporting, measurement and analytics.
NeoClinical™ is headed by award-winning communications executives who have managed global campaigns for some of the world’s leading consumer and healthcare companies.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10440216.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
4. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
5. Neogen Launches Fully Quantitative Lateral Flow Test for DON
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. iHealth Lab Launches Personalized Web Portal to Store Your Vitals
8. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
9. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
10. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
11. ERT Launches New Website to Support Significant Commercial Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... enabling healthier lives through the development of innovative products ... the United States denied its ... the claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 ... criteria established by the Supreme Court,s Mayo Collaborative Services ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, former ... of the University of North Carolina Kenan-Flagler Business School effective June ... UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes and ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
Breaking Biology News(10 mins):